Pfenex focuses on biosimilars post IPO
Revenues from protein production will decline as Pfenex shifts attention to its biosimilar pipeline, the newly public company says.
Archives for September 1, 2014
CMO Kentucky Bioprocessing grows Ebola mAb from tobacco
ZMapp, the experimental Ebola therapy given to a handful of infected patients in West Africa, is being produced in tobacco plants for Mapp Biopharmaceutical by CMO Kentucky Bioprocessing in collaboration with drugmaker Defyrus.
Stem cells made available for API development by European biobank
A German biobank has made stem cells available to active pharmaceutical ingredient (API) firms this week in a bid to support industry drug development efforts.